Log In
BCIQ
Print this Print this
 

Vosoritide (BMN 111) (formerly BMN-111)

  Manage Alerts
Collapse Summary General Information
Company BioMarin Pharmaceutical Inc.
DescriptionAnalog of C-type natriuretic peptide (CNP; NPPC)
Molecular Target C-type natriuretic peptide (CNP) (NPPC)
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase II
Standard Indication Musculoskeletal (unspecified)
Indication DetailsTreat achondroplasia
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/03/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today